STOCK TITAN

Teleflex Stock Price, News & Analysis

TFX NYSE

Company Description

Overview

Teleflex Inc (TFX) is a global provider of specialty medical devices that focuses on enhancing patient safety and clinical outcomes. With a diverse portfolio spanning vascular access, interventional procedures, anesthesia, surgical applications, urology, and OEM manufacturing, Teleflex is deeply embedded in the healthcare value chain. Its products are designed to meet the rigorous demands of clinical settings, providing reliable and innovative solutions that address both routine and complex medical procedures.

Business Segments and Core Operations

Teleflex operates across several distinct business segments, including:

  • Vascular Access: Offering products that ensure effective and safe catheterization and vascular management.
  • Interventional Solutions: Providing minimally invasive devices and techniques that support procedural efficacy in treatments such as percutaneous interventions.
  • Anesthesia and Surgical Devices: Delivering critical tools and systems that improve procedural efficiency and patient safety in surgical environments.
  • Urology: Innovating through systems like the UroLift that aim to treat benign prostatic hyperplasia without compromising quality of life.
  • OEM Manufacturing: Supplying high-quality components and devices under contractual manufacturing agreements that meet global standards.

The company’s strategy involves leveraging robust clinical research, technological advancements, and a wide distribution network to serve healthcare providers in over 150 countries, with a strong emphasis on quality and regulatory compliance.

Innovation and Clinical Excellence

Teleflex is recognized for its commitment to advancing medical technology through continuous research and clinical trials. The company’s products undergo rigorous testing and clinical evaluations, which serve to validate their safety and efficacy in real-world applications. Innovations such as the UroLift system for minimally invasive urological procedures and advanced surgical stapling devices have set benchmarks in their respective sectors. By integrating data derived from head-to-head clinical trials and real-world analysis, Teleflex ensures that its solutions not only meet industry standards but also provide distinct advantages in patient management and procedural safety.

Market Position and Global Reach

Headquartered in Wayne, Pennsylvania, Teleflex has established a formidable market presence primarily in the United States, which accounts for a substantial portion of its business activities. The company’s international operations further reinforce its global footprint, enabling it to adapt to region-specific regulatory requirements and patient care demands. Teleflex’s broad geographic exposure and diversified revenue streams position it well within the competitive landscape of the medical device industry.

Commitment to Quality and Safety

At its core, Teleflex is dedicated to driving improvements in patient outcomes through devices that emphasize safety, reliability, and clinical effectiveness. The company’s comprehensive quality management practices and adherence to stringent regulatory standards ensure that every product delivered upholds the highest levels of performance. This commitment to quality enhances trust among healthcare providers and aligns with the overarching goal of advancing global healthcare standards.

Integration of Technology and Clinical Practice

Teleflex combines state-of-the-art engineering with deep clinical insight to address unmet needs in healthcare. Its technologies are designed to simplify complex procedures, reduce the risk of complications, and support healthcare professionals through every step of patient care. This synergy between technology and clinical practice is a key driver of Teleflex’s business model and operational success.

Conclusion

Overall, Teleflex Inc stands as a pivotal contributor to the medical technology field. Its diverse product offerings, backed by extensive clinical research and innovation, provide healthcare providers with the tools necessary to manage complex clinical scenarios with enhanced safety and efficiency. For investors and stakeholders in the healthcare industry, understanding Teleflex’s integrated approach offers valuable insights into a company that consistently demonstrates expertise, reliability, and a deep commitment to improving patient outcomes.

Stock Performance

$135.21
0.00%
0.00
Last updated: April 26, 2025 at 16:00
-28.93 %
Performance 1 year
$5.9B
Market Cap
44.7M
Shares outstanding

SEC Filings

No SEC filings available for Teleflex.

Financial Highlights

$3,047,324,000
Revenue (TTM)
$69,675,000
Net Income (TTM)
$1.48
Diluted EPS (TTM)
$635,739,000
Operating Cash Flow
2.29%
Net Profit Margin
4.96%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Teleflex (TFX)?

The current stock price of Teleflex (TFX) is $135.21 as of April 25, 2025.

What is the market cap of Teleflex (TFX)?

The market cap of Teleflex (TFX) is approximately 5.9B.

What is the revenue (TTM) of Teleflex (TFX) stock?

The trailing twelve months (TTM) revenue of Teleflex (TFX) is $3,047,324,000.

What is the net income of Teleflex (TFX)?

The trailing twelve months (TTM) net income of Teleflex (TFX) is $69,675,000.

What is the earnings per share (EPS) of Teleflex (TFX)?

The diluted earnings per share (EPS) of Teleflex (TFX) is $1.48 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Teleflex (TFX)?

The operating cash flow of Teleflex (TFX) is $635,739,000.

What is the profit margin of Teleflex (TFX)?

The net profit margin of Teleflex (TFX) is 2.29%.

What is the operating margin of Teleflex (TFX)?

The operating profit margin of Teleflex (TFX) is 4.96%.

What is the gross margin of Teleflex (TFX)?

The gross profit margin of Teleflex (TFX) is 55.87%.

What is the current ratio of Teleflex (TFX)?

The current ratio of Teleflex (TFX) is 2.27, indicating the company's ability to pay short-term obligations.

What is the gross profit of Teleflex (TFX)?

The gross profit of Teleflex (TFX) is $1,702,679,000 on a trailing twelve months (TTM) basis.

What is the operating income of Teleflex (TFX)?

The operating income of Teleflex (TFX) is $151,013,000.

What is Teleflex Inc's core business?

Teleflex Inc is a global provider of specialty medical devices, offering solutions in vascular access, interventional procedures, anesthesia, surgical applications, and urology.

Which markets does Teleflex primarily serve?

Teleflex serves healthcare providers in over 150 countries, with a significant market presence in the United States and a diverse international footprint.

What are some key product segments of Teleflex?

Key product segments include vascular access solutions, interventional devices, anesthesia and surgical equipment, urological systems like the UroLift, and OEM manufacturing products.

How does Teleflex emphasize patient safety?

Teleflex focuses on high-quality manufacturing, rigorous clinical testing, and advanced product design to ensure effective and safe solutions that improve patient outcomes.

What role does clinical research play at Teleflex?

Clinical research is integral at Teleflex; the company supports its product development with extensive clinical trials and real-world studies to validate safety and efficacy.

How does Teleflex maintain its competitive edge in the industry?

By investing in innovative solutions, leveraging robust clinical evidence, and maintaining a diversified portfolio, Teleflex effectively addresses unmet clinical needs in various medical specialties.

What distinguishes Teleflex's approach to medical device innovation?

Teleflex integrates advanced engineering with clinical expertise, focusing on safety, efficiency, and patient outcomes, all backed by extensive research and regulatory compliance.

How is Teleflex positioned within the global healthcare market?

With a strong US market presence and significant international operations, Teleflex is well-positioned to meet diverse regulatory and clinical demands, ensuring a global impact in the medical device industry.